Who says you re competent?

Size: px
Start display at page:

Download "Who says you re competent?"

Transcription

1 Who says you re competent? Eric Kastango MBA, RPh, FASHP ClinicalIQ, LLC 1

2 Disclaimer Although I am a member of the USP Sterile Compounding Expert Committee, I am speaking today in my individual capacity and not as a member of the Committee or as a USP representative. The views and opinions presented are entirely my own. They do not necessarily reflect the views of USP, nor should they be construed as an official explanation or interpretation of <797>. 2

3 "For 42 years, I made small, regular deposits of education, training and experience... and the experience balance was sufficient that on January 15th I could make a sudden, large withdrawal Chesley Sullenberger 3

4 Why Training? It is a requirement State Board of Pharmacy The Joint Commission Hospital policy What do your employees need to know to do their job accurately and consistently? Who trains new employees? What does a pharmacist need to know? What does a technician need to know? Is there an opportunity to revisit how we educate and train employees? 4

5 Brutal Facts March 2011, Alabama Serratia marcescens associated infections and deaths associated with contaminated parenteral nutrition prepared by a compounding pharmacy Scenario At least nineteen case of infection, 9 deaths from Serratia infection associated with parenteral nutrition (PN). Pharmacy used nonsterile components to prepare the PN-amino acids. The environmental contamination (sink, mixing tank, stirrer) that was found (genotype/phenotype) was the same found in the infected patients. Root Cause (probable) Untrained compounding personnel Failure to achieve sterility Improper use of filter

6 Training Quality On your first day, you brought a high-level of experience and knowledge to the organization. In training, we capitalized on your existing skills and began an educational development process to standardize your compounding skills and ensure that you were adequately prepared to meet the daily challenges of aseptic processing. Your participation and preparation prior to any training program is critical to your success. We can only build on the knowledge base you bring to training. Each of us must maintain our own ongoing personal training. Adapted from Continental Airlines Pilot Training Manual,

7 How, What and Where? Listservs ASHP Connect, IJPC, APIC, PDA, PMF Pharmacy, Purchasing and Products Magazine ( Almost every topic re: USP Chapter <797> has been written about at least once American Society of Health-System Pharmacists Compounding Sterile Preparation Series CriticalPoint,LLC The Course in Sterile Compounding The Virtual Compounder Lab Safety Corporation VALITEQ series 7

8 8

9 9

10 10

11 11

12 12

13 Conscious Competence Learning Matrix Awareness: Learning is occurring Knowledge Ability Competency Proficiency Ignorance Wisdom: Knowledge is intuitive

14 Does Training = Learning? We should probably stop using the word training, but just in case, let s review why it s inappropriate. Training is something you do to someone. Learning is something people do for themselves. You hope people learn from training, for that is the objective. Adapted from 8 Dirty Words, Jay Cross. 14

15 One only knows something if one can explain it Giambatista Vico, 1710, constructivist philosopher Adults take knowledge and connect it to other information they hold true, changing their understanding in the process, as in this mock hazardous drug cleanup exercise. 15

16 Training Quality Content unaccompanied by monitoring and coaching is not always successfully transferred to practice, and may diminished (wear off or fade) over time requiring periodic reminder sessions. Education must be repeated as staff turnover 16

17 Four-step process Job Instructional Breakdown Prepare the worker. The trainee is prepared by getting him or her interested in the job and then asking him or her about similar experience. For example, "We re going to learn how to do finger-tip sampling. What do you know about this job?" The trainee is put into the correct position to do the job. This reinforces readiness to learn how to do, rather than simply what to do. Present the operation. The trainer gives verbal instructions demonstrating the job and stating the important steps, repeats the process to add the key points and repeats it again to add the reasons for each key step. Try out performance. The trainee repeats the process, first doing the job without talking, then stating the important steps, then adding the key points and finally listing the reasons why. By now, the trainer will know whether the trainee has learned the process or whether some of the steps need to be repeated. Follow- up. After training, the trainer follows up and continues to coach, providing input and answering questions for the trainee until the trainer is confident the operator knows the job. 17

18 What is Glove Fingertip Sampling Glove Fingertip Sampling detects the presence of microorganisms on the fingertips of gloves. Squamous cells are normally shed from the surface of the human body at a rate of a million or more per hour and these skin particles are laden with microorganisms. A Pharmacy ES Plan is a program of activities to measure both the microorganisms and particles in the controlled compounding environment and on surfaces like gloves. Copyright CriticalPoint - All rights reserved

19 What is Glove Fingertip Sampling? Detects transient organisms on gloves from poor aseptic technique or improper disinfection of gloves. Is one part of an ES program that also includes Air Sampling and Surface Sampling. Uses agar plates to test for microorganisms. Copyright CriticalPoint - All rights reserved

20 Poll questions Do you conduct glove fingertip sampling testing on your employees? YES NO 20

21 Initially Where and When? Prior to preparing CSPs for human use Must complete successfully at least 3x Successfully complete an initial hand hygiene and garbing competency evaluation and gloved fingertip/thumb sampling procedure Sample taken immediately after donning sterile gloves to verify that compounder can garb without contaminating hands Passing results: Colony Forming Units (CFU) both hands = 0. Copyright CriticalPoint - All rights reserved

22 Where and When? (continued) Ongoing basis 1. At the time Personnel Aseptic Media Fill is performed 1. Annually (low/medium risk) 2. Semiannually (high risk) 2. DO NOT disinfect gloves with sterile 70% IPA immediately prior to testing (false negative). 3. Obtain sample while employee is in ISO Class 5 environment during preparation of personnel media-fill units but not immediately after gloves have been disinfected with sterile 70% IPA. 4. Passing results if collected in ISO Class 5 air: 3 CFU Copyright CriticalPoint - All rights reserved

23 5 Stages of Glove Fingertip Sampling The following slides will provide a step-by-step process to help you to properly perform Glove Fingertip Sampling. It may help to remember the proper sequence by using the acronym PSOID: Prepare Set-up Obtain Incubate Document Copyright CriticalPoint - All rights reserved

24 Performing Glove Fingertip Sampling The following section leads you through the process of performing glove fingertip sampling. The entire process is broken down to individual steps that are easy to understand, and are generally considered basic steps to take at any pharmacy. However, it is important to read your own pharmacy s SOP (standard operating procedure) to be knowledgeable about specific requirements at your organization. Copyright CriticalPoint - All rights reserved

25 Gather Supplies 2 TSApl (tryptic soy agar with polysorbate and lecithin plates) needed for sampling, plus one extra of the same lot number to be used as a field control Tape Black Permanent (e.g. Sharpie) Marker ES Documentation Form Pen Sterile Gloves Sterile 70% isopropyl alcohol (IPA) Lint free wipes Bin to bring supplies into cleanroom Copyright CriticalPoint - All rights reserved

26 Set-Up Prep Area Lay supplies out on a clean counter which has been wiped down with sterile IPA. Allow plates to come to room temperature. Remove outer packaging of media. Transfer three plates to counter. Replace unused plates in refrigerator. Copyright CriticalPoint - All rights reserved

27 How to Inspect Media Inspect each plate for: Packaging integrity: do NOT use if package integrity is compromised. Growth: Do NOT use if growth is present. If growth is present, report this to the manufacturer and obtain a replacement lot. Expiration dates: do NOT use if plates are expired. Copyright CriticalPoint - All rights reserved

28 Poll question Do you inspect your media prior to using it? Packaging integrity Growth Shrinkage 28

29 Label Plates Label the back of each plate using the black Sharpie marker; include: Employee initials LH (left hand) plate RH (right hand) plate Date Time taken Sampler s initials Label control plate as control and tape the top to the bottom in 2 places. Place each plate back into the clean bin after it is labeled. Copyright CriticalPoint - All rights reserved

30 Document Media Document the following on the Glove Fingertip Form: Name of the person obtaining the plates Date samples obtained Manufacturer Lot # of medium Expiration date of medium For the initial Test CFU Action Level is Zero Copyright CriticalPoint - All rights reserved

31 Enter Buffer Area Bring clean bin containing supplies into the ante area. Perform hand cleansing and garbing following your pharmacy s established policy and procedure. Enter buffer area and observe the identified employee compounding. Copyright CriticalPoint - All rights reserved

32 Identify and Sample Employee Perform as part of the initial employee garbing and gowning assessment process Employee to perform garbing and gloving procedure with sterile gloves Employee must NOT disinfect their gloves PRIOR to taking the sample. All employees must be successfully complete an initial garbing and gloving exercise three times with ZERO (0) CFUs. Copyright CriticalPoint - All rights reserved

33 Poll Question Have all employees who compound sterile preparations successfully demonstrated proficiency in donning sterile gloves with ZERO cfus? YES NO 33

34 Identify and Sample Employee (continued) Sample both of employee s gloved hands upon completing the compounding procedure (media fill or other) Employee must NOT disinfect gloves PRIOR to taking the sample. Carefully remove the cover of the agar plate without touching the interior surface of the plate. Place the cover of the plate face up on a clean surface in either the primary or secondary engineering controls. Copyright CriticalPoint - All rights reserved

35 Obtaining the Sample The compounder should gently touch the agar surface with all fingertips and thumbs of one hand. The fingertips and thumbs should create a slight impression on the agar surface. The plate should be covered with the lid and the sampling procedure should be repeated for the other hand. Copyright CriticalPoint - All rights reserved

36 Seal the Samples and Document Secure the top and bottom of each plate with tape in at least 2 locations. Place all sealed plates into the clean bin with the control plate and other supplies. Remove bin with all supplies and sealed plates from cleanroom. Copyright CriticalPoint - All rights reserved

37 Discard Gloves and Wash Hands At the conclusion of the sampling, the compounder should remove and discard the sampled gloves. The employee must wash hands and don a fresh pair of gloves before starting any new compounding. Copyright CriticalPoint - All rights reserved

38 Incubate Samples Invert the plates so that they are upside down and immediately place them into the incubator. Plates should be incubated for 48 hours at 35 C + 2 C. Document the time the plates were placed in the incubator. Copyright CriticalPoint - All rights reserved

39 Reading the Results When incubation is complete, remove the plates from the incubator. Without opening the plate, read the results by counting the number of individual colony forming units (CFUs) that appear on the plate. Read the control plate; it should have no CFUs. Document the results in the correct space on the Glove Fingertip form that corresponds to the left or right hand. After reading the plates, they need to be properly disposed of as hazardous waste. Copyright CriticalPoint - All rights reserved

40 How to Interpret and Documents Results Test results are said to fail if the number of CFUs per 5 fingers & thumb exceed Zero (0) for the 3 initial tests and 4 or more CFUs for subsequent tests. Copyright CriticalPoint - All rights reserved

41 Documentation Complete all required elements of the Glove Fingertip documentation form. File the form for Manager review per established policy. Discard plates that are within established limits. Copyright CriticalPoint - All rights reserved

42 How to Handle Out of Limit CFUs If any CFU counts exceed established levels, retain the plate(s) in question. Do not discard any plates bearing unacceptable results. Report out of limit results to the appropriate manager immediately. Depending upon your institution s procedures, additional action will probably be required; this will usually involve retraining the compounder regarding hand hygiene, garbing procedures, and glove disinfection and then retesting them. This plate has more than 10 CFUs Copyright CriticalPoint - All rights reserved

43 Training in the USP <797> Compliance Framework Understand Regulation Assess Risk Level Identify Compliance Gap Develop Action Plan Implement Compliance Plan Competency & Control Training can help: Assimilate new staff: get into control, educate on a facility s practices, build baseline knowledge to become compliant with the way we do things Make sure everybody does it the same way according to policy and procedure. Maintain competency: remain in a state of compliance by demonstrating continued competency This is reflected in the compliance framework: get into control, then stay in control. Training and education is a key component of the compliance process: not a one-time event, but a continuing cycle of training, assessment, and improvement. Chapter <797> Compliance State of Compliance (point in time) Compliance process imagery licensed under , 2010 Clinical IQ, LLC. Some rights reserved. 43

44 Ways to evaluate your training Consider evaluating your training activities in four key areas: Is it appealing? Is it dynamic? Is it practical and job related? Is it authoritative? Will staff want to engage in the training program, or view it as a check the box exercise? What can be done to improve appeal? Introducing new learning methods? Is it updated to include recent changes (like the new chapter requirements!) or to reflect literature that has been published with best practices? Is there a clear linkage between what people need to do in their job, and the training they receive? Do staff receive feedback based on observations before and after training takes place? Does the training reflect processes that take place at the facility, and do they accurately communicate the concepts and requirements of the chapter? 44

45 Considerations for Training Program Development Recognize that USP <797> Changes Ingrained Behavior Research shows that training plays a big role in changing ingrained behaviors, particularly if new practices are different from what people know from the their experience Some compounding processes have critical steps or precise order. Training does two things: explain why it needs to be done correctly (rationale), and how to do it (process) Incorporate JIBs or checklists Opportunity to emphasize professional skills development Enlightened facilities view training as an opportunity to improve skills, morale, and engagement vs. a simple requirement. Supported by the literature Studies show that using multiple training techniques increases retention and competency (therefore didactic and hands on requirements for critical compounding steps) Addition of other methods (such as simulation) can be expected to yield further improvements 45

46 Excellence is an art won by training and habituation. We do not act rightly because we have virtue or excellence, but we rather have those because we have acted rightly. We are what we repeatedly do. Excellence, then, is not an act but a habit. Aristotle 46

47 Thank you My contact information: Eric S. Kastango, MBA, RPh, FASHP Clinical IQ, LLC 184 Columbia Turnpike, Suite 4, #282 Florham Park, NJ

USP <797> Compliance Common Challenges and Potential Solutions

USP <797> Compliance Common Challenges and Potential Solutions USP Compliance Common Challenges and Potential Solutions Angela Yaniv, Pharm.D Assistant Director - Sterile Products May 2, 2017 - OSHP Annual Meeting Angela Yaniv has no actual or potential conflict

More information

Sterile Compounding elearning Course Curriculum 28 lessons with 33 hours of CE. Fundamentals of Sterile Compounding (8 lessons/8 hours CE)

Sterile Compounding elearning Course Curriculum 28 lessons with 33 hours of CE. Fundamentals of Sterile Compounding (8 lessons/8 hours CE) Sterile Compounding elearning Course Curriculum 28 lessons with 33 hours of CE CriticalPoint s Sterile Compounding elearning curriculum is written by industry experts and covers both Chapter and

More information

Sterile Compounding elearning Course Curriculum 28 lessons with 33 hours of CE. Fundamentals of Sterile Compounding (8 lessons/8 hours CE)

Sterile Compounding elearning Course Curriculum 28 lessons with 33 hours of CE. Fundamentals of Sterile Compounding (8 lessons/8 hours CE) Sterile Compounding elearning Course Curriculum 28 lessons with 33 hours of CE Fundamentals of Sterile Compounding (8 lessons/8 hours CE) The History of Compounding and USP Sterile Compounding Chapters

More information

2008 ASHP Summer Meeting Seattle, Washington Educational Session Abstracts

2008 ASHP Summer Meeting Seattle, Washington Educational Session Abstracts 2008 ASHP Summer Meeting Seattle, Washington Educational Session Abstracts 116 USP Update 2008 and Personnel-Related Environmental Sampling Trissel, L.A. TriPharma Research, P.O. Box 265, Cashiers,

More information

PHARMACY IV ADMIXTURE

PHARMACY IV ADMIXTURE PHARMACY IV ADMIXTURE Pharmacy 483 January 18, 2007 Kim Donnelly Affiliate Assistant Professor kimdon@u.washington.edu Pharmacist is responsible for ensuring that compounded sterile preparations are properly

More information

Sterile Compounding Safety

Sterile Compounding Safety Sterile Compounding Safety I International Congress on Patient Safety ISMP Brazil and V International Forum on Patient Safety: Medication Errors Eric S. Kastango, MBA, RPh, FASHP President/CEO Clinical

More information

Compounding Aseptic Isolators (CAI) James T Wagner

Compounding Aseptic Isolators (CAI) James T Wagner Compounding Aseptic Isolators (CAI) James T Wagner jimwagner@cenvironment.com Disclaimer "Although I am a member of the USP Sterile Compounding Expert Committee, I am speaking today in my individual capacity

More information

PHARMACY IV ADMIXTURE. Pharmacy 483 January 17, 2006 Kim Donnelly Affiliate Associate Professor

PHARMACY IV ADMIXTURE. Pharmacy 483 January 17, 2006 Kim Donnelly Affiliate Associate Professor PHARMACY IV ADMIXTURE Pharmacy 483 January 17, 2006 Kim Donnelly Affiliate Associate Professor Pharmacist is responsible for ensuring that compounded sterile preparations are properly prepared, labeled,

More information

Position: Sr. Director of Education and Data - NHIA, VP of Research - NHIF

Position: Sr. Director of Education and Data - NHIA, VP of Research - NHIF Comment Submission Template for: General Chapter Pharmaceutical Compounding Sterile Preparations Revision proposed in Pharmacopeial Forum 41(6) Nov/Dec 2015 Send completed template to CompoundingSL@usp.org

More information

UNDER SECRETARY FOR HEALTH S INFORMATION LETTER MICROBIOLOGICAL ASSESSMENT OF PHARMACEUTICAL CLEANROOMS

UNDER SECRETARY FOR HEALTH S INFORMATION LETTER MICROBIOLOGICAL ASSESSMENT OF PHARMACEUTICAL CLEANROOMS DEPARTMENT OF VETERANS AFFAIRS Veterans Health Administration Washington DC 20420 IL 10-2006-008 In Reply Refer To: 10NB UNDER SECRETARY FOR HEALTH S INFORMATION LETTER MICROBIOLOGICAL ASSESSMENT OF PHARMACEUTICAL

More information

compounding area based on environmental sampling and cleaning product type. Antiseptics and determine the appropriate use of each.

compounding area based on environmental sampling and cleaning product type. Antiseptics and determine the appropriate use of each. The pharmacist will be able to: 1. Determine a best practice for cleaning their compounding area based on environmental sampling and cleaning product type. 2. Discuss the difference between Disinfectants

More information

Enhanced Sterile Medication Compounding Evaluation

Enhanced Sterile Medication Compounding Evaluation Enhanced Sterile Medication Compounding Evaluation Robert Campbell, PharmD Director, Standards Interpretation Hospital /Ambulatory Programs Director, Medication Management Division of Healthcare Quality

More information

Approval Block. Prepared by: Signature Date. Evan Parnell 18 JUN Reviewed by: Signature Date. Brian Flynn 18 JUN 2014

Approval Block. Prepared by: Signature Date. Evan Parnell 18 JUN Reviewed by: Signature Date. Brian Flynn 18 JUN 2014 ATS-SOI-5805 Page: 1 of 5 Approval Block Prepared by: Signature Date Evan Parnell 18 JUN 2014 Reviewed by: Signature Date Brian Flynn 18 JUN 2014 Approved by: Signature Date Kristal Jewell 18 JUN 2014

More information

Lessons to be Learned from the NECC 483

Lessons to be Learned from the NECC 483 Lessons to be Learned from the NECC 483 Eric S. Kastango, MBA, RPh, FASHP President/CEO Clinical IQ, LLC and CriticialPoint,LLC Madison, NJ and Gaithersburg, MD Speaker Disclosures "Although Eric Kastango

More information

USP <797> and Environmental Sampling

USP <797> and Environmental Sampling USP and Environmental Sampling Participants will be in listen only mode. 9 a.m. (PT) Download the PDF: https://www.emlab.com/m/media/usp797-webinar.pdf Presented by: Michael Berg, Ph.D. Continuing

More information

Pharmaceutical Compounding Sterile and Nonsterile Preparations. Jeanne Sun, PharmD

Pharmaceutical Compounding Sterile and Nonsterile Preparations. Jeanne Sun, PharmD Pharmaceutical Compounding Sterile and Nonsterile Preparations Jeanne Sun, PharmD Agenda Legal Framework Overview Pharmaceutical Compounding Nonsterile Preparations Pharmaceutical Compounding

More information

PURE CULTURE TECHNIQUES

PURE CULTURE TECHNIQUES PURE CULTURE TECHNIQUES Most specimens (from animal tissue, plant tissue, or environmental samples) will be mixed, with a variety of bacteria (or other microorganisms). A single gram of feces, for example,

More information

Important Updates in USP <797> and USP <823> Eric S. Kastango, MBA, BS Pharm, FASHP Clinical IQ, LLC & CriticalPoint, LLC Madison, New Jersey

Important Updates in USP <797> and USP <823> Eric S. Kastango, MBA, BS Pharm, FASHP Clinical IQ, LLC & CriticalPoint, LLC Madison, New Jersey Important Updates in USP and USP Eric S. Kastango, MBA, BS Pharm, FASHP Clinical IQ, LLC & CriticalPoint, LLC Madison, New Jersey Disclosures Principal-Clinical IQ, LLC Healthcare consulting

More information

4.5 Compounding Compounding in Licensed Pharmacies.

4.5 Compounding Compounding in Licensed Pharmacies. 0 0 0. Compounding. Compounding in Licensed Pharmacies. (a) Compounding means any of the following activities occurring in a licensed pharmacy, by or under the supervision of a licensed pharmacist, pursuant

More information

Evaluation of a Novel Non-Sterile Glove Dispensing System Uyen Nguyen

Evaluation of a Novel Non-Sterile Glove Dispensing System Uyen Nguyen Evaluation of a Novel Non-Sterile Glove Dispensing System Uyen Nguyen Edited by: Michael Diamond Reviewed by: Andrew Duong Disclaimer: The author of this report and declare no conflict of interest with

More information

The Current State of Compounding Standards: What Happens Next? Eric S. Kastango, MBA, RPh, FASHP Clinical IQ, LLC & CriticalPoint, LLC Madison NJ

The Current State of Compounding Standards: What Happens Next? Eric S. Kastango, MBA, RPh, FASHP Clinical IQ, LLC & CriticalPoint, LLC Madison NJ The Current State of Compounding Standards: What Happens Next? Eric S. Kastango, MBA, RPh, FASHP Clinical IQ, LLC & CriticalPoint, LLC Madison NJ Disclosure Information The Current State of Compounding

More information

Infection and Intravenous Drug Delivery: A Long and Tumultuous Relationship

Infection and Intravenous Drug Delivery: A Long and Tumultuous Relationship Infection and Intravenous Drug Delivery: A Long and Tumultuous Relationship Eric Wenzler, PharmD, BCPS, AAHVIP Assistant Professor University of Illinois at Chicago Disclosures I have no actual or potential

More information

Implementing the Process Supplier Approval Program

Implementing the Process Supplier Approval Program Implementing the Process Supplier Approval Program About This Program In the Supplier Approval Series, we will take you through all of the steps necessary to identify a supplier/manufacturer that is safe

More information

Overview of a sterility assurance program for PET drugs

Overview of a sterility assurance program for PET drugs Coalition for PET Drug Approval Radiopharmaceutical Sciences Council Overview of a sterility assurance program for PET drugs Eric Webster, PETNET Solutions Disclosures Employee of PETNET Solutions, a Siemens

More information

Improving the Safety of Compounded Preparations - USP <800> Compliance in Every Day Practice

Improving the Safety of Compounded Preparations - USP <800> Compliance in Every Day Practice Improving the Safety of Compounded Preparations - USP Compliance in Every Day Practice PSSNY Annual Convention, Westchester Hilton, Rye Brook, NY Sunday, June 25th at 9:00 AM Lou Diorio, RPh, FAPhA

More information

Environmental Monitoring of Aseptic Processing Areas - 2

Environmental Monitoring of Aseptic Processing Areas - 2 Environmental Monitoring of Aseptic Processing Areas - 2 A war against an invisible enemy DCVMN - Víctor Maqueda - May 30, 31, June 1 2016 1 Active Air Monitoring (Viables) Air Sieve Samplers Draw air

More information

USP <800> PRACTICAL COMPLIANCE STRATEGIES FOR ALL PRACTICE SETTINGS

USP <800> PRACTICAL COMPLIANCE STRATEGIES FOR ALL PRACTICE SETTINGS USP PRACTICAL COMPLIANCE STRATEGIES FOR ALL PRACTICE SETTINGS NYSCHP Annual Assembly The Saratoga Hilton, Saratoga Springs, NY Sunday, April 22th at 8 AM LOU DIORIO, RPH, FAPHA PRINCIPAL LDT HEALTH

More information

The ABCs and Challenges of GMP The American Experience

The ABCs and Challenges of GMP The American Experience The ABCs and Challenges of GMP The American Experience The Canadian Association of Nuclear Medicine Toronto, Ontario April 22, 2017 Reiko Oyama, R.Ph., B.C.N.P. Washington University School of Medicine

More information

USP <797>/<800> Cleanroom Design & Environmental Monitoring. A presentation for HealthTrust Members November 14, 2018

USP <797>/<800> Cleanroom Design & Environmental Monitoring. A presentation for HealthTrust Members November 14, 2018 USP / Cleanroom Design & Environmental Monitoring A presentation for HealthTrust Members November 14, 2018 Andrew King, USP Compliance and Engineering Specialist CETA Member RCCP-SC Disclosures

More information

ASEPTIC TRANSFER & PURE CULTURE TECHNIQUES

ASEPTIC TRANSFER & PURE CULTURE TECHNIQUES ASEPTIC TRANSFER & PURE CULTURE TECHNIQUES GENERAL GUIDELINES & REMINDERS: SAFETY: NO EATING OR DRINKING IN THE LAB! Wash your hands with soap both BEFORE and AFTER lab, and, in addition, when you have

More information

TECHNICAL LEAFLET. MEDI-MEDIA-FILL KIT SUPPLY PACKAGE (Code: MR-25/S)

TECHNICAL LEAFLET. MEDI-MEDIA-FILL KIT SUPPLY PACKAGE (Code: MR-25/S) TECHNICAL LEAFLET MEDI-MEDIA-FILL KIT SUPPLY PACKAGE (Code: MR-25/S) TEST AGAR PLATES FOR PERSONNEL AND ENVIRONMENTAL MICROBIOLOGICAL MONITORING COMPONENTS: Test Agar Plates Data Log Sheet Technical Leaflet

More information

STUDENT PAGE. Using Sterile Technique to Inoculate Bacterial Plates

STUDENT PAGE. Using Sterile Technique to Inoculate Bacterial Plates Using Sterile Technique to Inoculate Bacterial Plates A sterile, or aseptic, technique is used to prevent microbial organisms from contaminating any surface other than the specific location where they

More information

Aseptic Techniques. A. Objectives. B. Before coming to lab

Aseptic Techniques. A. Objectives. B. Before coming to lab Aseptic Techniques A. Objectives Become familiar with 1. The ubiquity of microorganisms (see Note 1) 2. Aseptic techniques (see Note 2) 3. Standard methods for growing/observing microorganisms (see Note

More information

USP Chapter <797> & <800> Testing Supplies

USP Chapter <797> & <800> Testing Supplies How clean are your testing supplies? USP Chapter & Testing Supplies The first aseptic products built to minimize risk starting with the packaging itself Smarter, Cleaner, Convenient Cultivate

More information

Baxa Corporation. Technical Paper. Environmental Controls for Sterile Compounding

Baxa Corporation. Technical Paper. Environmental Controls for Sterile Compounding Baxa Corporation Environmental Controls for Sterile Compounding Technical Paper A guidance document on developing sterile preparation areas to meet the USP requirements for low and medium risk compounded

More information

Thanks and acknowledgement to Pamela Isaacs for the content and slides in this presentation.

Thanks and acknowledgement to Pamela Isaacs for the content and slides in this presentation. A PRESCRIPTION FOR INFECTION PREVENTION ROUNDING IN THE PHARMACY EVELYN COOK Thanks and acknowledgement to Pamela Isaacs for the content and slides in this presentation. OBJECTIVES: 1. Discuss recent outbreaks

More information

Developed and Presented by: Wisconsin Healthcare Engineering Association

Developed and Presented by: Wisconsin Healthcare Engineering Association Infection Control Risk Assessment (ICRA) Developed and Presented by: Wisconsin Healthcare Engineering Association What is an ICRA? An Infection Control Risk Assessment is a tool devised to protect patients

More information

Workflow Strategies to Minimize Personnel and Environmental Exposure to Hazardous Drugs in the Compounding Pharmacy

Workflow Strategies to Minimize Personnel and Environmental Exposure to Hazardous Drugs in the Compounding Pharmacy Workflow Strategies to Minimize Personnel and Environmental Exposure to Hazardous Drugs in the Compounding Pharmacy Bryan Prince, LAB RED Pharmacy Consultants Sponsored by Workflow Strategies to Minimize

More information

USP800: A quick summary and disposal. Brenda Denson, Pharm.D.

USP800: A quick summary and disposal. Brenda Denson, Pharm.D. USP800: A quick summary and disposal Brenda Denson, Pharm.D. Objectives Review current USP800 guidelines on destruction of hazardous medications. Illustrate how a local pharmacy demonstrates compliance

More information

NHS QA Symposium, September 2013

NHS QA Symposium, September 2013 1 www.pmtgb.com Germany - Benelux T o g e t h e r W e c r e a t e S o l u t i o n s France - Great Britain NHS QA Symposium, September 2013 John Cobb Microbiology Support Manager 2 www.pmtgb.com Germany

More information

TRANSFER OF BACTERIA USING ASEPTIC TECHNIQUE

TRANSFER OF BACTERIA USING ASEPTIC TECHNIQUE TRANSFER OF BACTERIA USING ASEPTIC TECHNIQUE GENERAL GUIDELINES: Safety Wear a lab coat and have your goggles on! ALWAYS disinfect the tables BEFORE and AFTER lab. Wash your hands with soap both BEFORE

More information

Pharmacy Quality Assurance Commission Sterile Compounding [USP <797>] Self-Assessment Compliance Checklist

Pharmacy Quality Assurance Commission Sterile Compounding [USP <797>] Self-Assessment Compliance Checklist STATE OF WASHINGTON Pharmacy Quality Assurance Commission Sterile Compounding [USP ] Self-Assessment Compliance Checklist Introduction: This checklist includes the reported principal competencies,

More information

Guidelines for QualiTru Line Sampling

Guidelines for QualiTru Line Sampling Guidelines for QualiTru Line Sampling QUALITRU GUIDELINES FOR LINE SAMPLING 1. Purpose: Following these Standard Operating Procedures, farms and processing plants may use the QualiTru aseptic sampling

More information

Infection Prevention for Pharmacy Compounding

Infection Prevention for Pharmacy Compounding Infection Prevention for Pharmacy Compounding Samuel M. Eberwein, PharmD, MS, BCPS November 5, 2018 Infection Prevention Starts with Regulation Compounding Regulation has a Rich History 2019 USP

More information

How to Handle Excursions in Environmental Monitoring (EM) and Personnel Monitoring (PM) in an Aseptic Processing Plant

How to Handle Excursions in Environmental Monitoring (EM) and Personnel Monitoring (PM) in an Aseptic Processing Plant How to Handle Excursions in Environmental Monitoring (EM) and Personnel Monitoring (PM) in an Aseptic Processing Plant Randy Hutt, Ph.D. Associate Director Sterility Assurance and Microbiology Luitpold

More information

USP CHAPTER <797> INTRODUCTION RISK LEVELS

USP CHAPTER <797> INTRODUCTION RISK LEVELS USP CHAPTER INTRODUCTION RISK LEVELS Introduction: The objective of this chapter is to describe conditions and practices to prevent harm, including death, to patients that could result from 1) microbial

More information

USP<800> A Deeper Dive. Joe Cabaleiro R.Ph.

USP<800> A Deeper Dive. Joe Cabaleiro R.Ph. USP A Deeper Dive Joe Cabaleiro R.Ph. Consultant/Facilitator LP3 Network Inc. Consultant MEDISCA Network Inc. Senior Associate; Gates HealthCare Associates, Inc. Disclosures Joe Cabaleiro is a consultant

More information

MINIMUM REQUIREMENTS FOR A VENDOR

MINIMUM REQUIREMENTS FOR A VENDOR MINIMUM REQUIREMENTS FOR A VENDOR When outsourcing the production of sterile products the first step in vendor evaluation is to see if they meet the minimum requirements. We ve developed a group of questions

More information

Webinar Expert Module 3: GMP Inspections Dupont

Webinar Expert Module 3: GMP Inspections Dupont Webinar Expert Module 3: GMP Inspections Dupont 26 January & 9 February 2018 GOP-Innovations your Partner for Practical Training and e-learning Milenko Pavičić Pharmaceutical microbiologist, trainer, coach

More information

To help you become familiar and comfortable with the different supplies and materials required for HIV rapid testing.

To help you become familiar and comfortable with the different supplies and materials required for HIV rapid testing. Module 7 Preparation for Testing Supplies and Kits Purpose To help you become familiar and comfortable with the different supplies and materials required for HIV rapid testing. Pre-requisite Modules Learning

More information

Study Summary. Results: All tested media-filled vials were negative for growth of any microorganisms.

Study Summary. Results: All tested media-filled vials were negative for growth of any microorganisms. A 7 Days Microbial Ingress Test of Single Use Vials Utilizing the EQUASHIELD Closed System Drug Transfer Device Study by Nelson Laboratories (Salt Lake City, UT) 2013, updated in 2014* Study Summary Abstract:

More information

September 2, Division of Dockets Management (HFA-305) Food and Drug Administration 5630 Fishers Lane, Rm Rockville, MD 20852

September 2, Division of Dockets Management (HFA-305) Food and Drug Administration 5630 Fishers Lane, Rm Rockville, MD 20852 September 2, 2014 Division of Dockets Management (HFA-305) Food and Drug Administration 5630 Fishers Lane, Rm. 1061 Rockville, MD 20852 Re: FDA Draft Guidance: Current Good Manufacturing Practice Interim

More information

FDA s Guidance for Industry

FDA s Guidance for Industry Sterile Drug Products Produced by Aseptic Processing - CGMPs Midwest FDC Conference November 4 2005 Susan Bruederle, Investigator FDA / ORA / Central Region Chicago District / Hinsdale IL FDA s Guidance

More information

Microbiology Testing: USP requirements for Sterile and Nonsterile Preparations Webinar Q&A

Microbiology Testing: USP requirements for Sterile and Nonsterile Preparations Webinar Q&A USP Antimicrobial Effectiveness Testing Microbiology Testing: Webinar Q&A 1. If a base ingredient is designed for the purpose of compounding a specific type of preparation does this forgo the necessity

More information

Facility Design for Pharmacy Operation. Full-Scale Nuclear. Slides are not to be reproduced without permission of author.

Facility Design for Pharmacy Operation. Full-Scale Nuclear. Slides are not to be reproduced without permission of author. Facility Design for Pharmacy Operation Full-Scale Nuclear in a Hospital Setting Neil A. Petry, MS, RPh, BCNP, FAPhA Clinical i l Assistant t Professor in Radiology Director, Radiopharmacy Services Duke

More information

2017 Diversion Specialists

2017 Diversion Specialists 2017 Diversion Specialists RUSSELL ODEGARD Chief Executive Officer DYNALABS RUSSELL ODEGARD Chief Executive Officer DYNALABS LOU DIORIO, RPh, FAPhA Principal LTD Health Solutions, Inc. Achieving Compliance

More information

Effect of two work practice changes on the microbial contamination rates of pharmacy-compounded sterile preparations

Effect of two work practice changes on the microbial contamination rates of pharmacy-compounded sterile preparations P R A C T I C E R E P O R T S Effect of two work practice changes on the microbial contamination rates of pharmacy-compounded sterile preparations LAWRENCE A. TRISSEL, JOSEPH A. GENTEMPO, LISA M. SAENZ,

More information

Why Do I Test, What Do I Test & When Do I Test It? Ross Caputo, PhD Chief Technical Officer Eagle Analytical Services

Why Do I Test, What Do I Test & When Do I Test It? Ross Caputo, PhD Chief Technical Officer Eagle Analytical Services Why Do I Test, What Do I Test & When Do I Test It? Ross Caputo, PhD Chief Technical Officer Eagle Analytical Services Disclosures I, Ross Caputo, declare no conflicts of interest, real or apparent, and

More information

Bioburden Contamination Control: A Holistic Overview

Bioburden Contamination Control: A Holistic Overview Bioburden Contamination Control: A Holistic Overview Scott Sutton, PhD Microbiology Network, Inc. Scott Sutton, PhD is the Principal of Microbiology Network, Inc (http:// microbiologynetwork.com/) a company

More information

Creating a Centralized Compounding Pharmacy within a Health System

Creating a Centralized Compounding Pharmacy within a Health System SALAS BLANCAS Amy Benner, PharmD Director of Central and Shared Services Scripps Health. Robert Miller, MS Quality Manager Scripps Health Ensuring the production of accurate and safe sterile compounded

More information

LABORATORY #2 -- BIOL 111 BACTERIAL CULTIVATION & NORMAL FLORA

LABORATORY #2 -- BIOL 111 BACTERIAL CULTIVATION & NORMAL FLORA LABORATORY #2 -- BIOL 111 BACTERIAL CULTIVATION & NORMAL FLORA OBJECTIVES After completing this exercise you should be able to: 1. Identify various types of media 2. Isolate bacteria using aseptic technique.

More information

Microbiological Methods

Microbiological Methods Microbiological Methods Making Media Pouring Culture Plates Sterile Technique Inoculating Plates and Culture Tubes Use of a Plate Counter to Estimate Microbial Population Densities Sterile Technique Sterile

More information

Microbiological Methods

Microbiological Methods Microbiological Methods Making Media Pouring Culture Plates Sterile Technique Inoculating Plates and Culture Tubes Use of a Plate Counter to Estimate Microbial Population Densities Culturing Microorganisms

More information

LUNCH AND LEARN. October 14, CE Activity Information & Accreditation

LUNCH AND LEARN. October 14, CE Activity Information & Accreditation LUNCH AND LEARN USP Chapter : What s on the Radar? October 14, 2016 Featured Speaker: Patricia C. Kienle, RPh, MPA, FASHP Director, Accreditation and Medication Safety Cardinal Health Innovative Delivery

More information

Environmental Monitoring Program

Environmental Monitoring Program Environmental Monitoring Program A EUROFINS WHITE PAPER This document by Eurofins is licensed under a Creative Commons Attribution 3.0 Unported License. AN AWARENESS GUIDE FOCUSED ON FINDING PATHOGENS

More information

for IND and RDRC Regulated PET Compounding

for IND and RDRC Regulated PET Compounding Overview of USP Chapter for IND and RDRC Regulated PET Compounding Distributed Manufacturing of PET Radiopharmaceuticals for Multi-Center Clinical Trials SNM, Annual Meeting Toronto, Ontario, Canada

More information

FLORIDA SOCIETY OF HEALTH SYSTEM PHARMACISTS NOVEMBER 4, 2016 JAMES T WAGNER CONTROLLED ENVIRONMENT CONSULTING

FLORIDA SOCIETY OF HEALTH SYSTEM PHARMACISTS NOVEMBER 4, 2016 JAMES T WAGNER CONTROLLED ENVIRONMENT CONSULTING Engineering Controls for Compliance with USP Chapters and FLORIDA SOCIETY OF HEALTH SYSTEM PHARMACISTS NOVEMBER 4, 2016 JAMES T WAGNER CONTROLLED ENVIRONMENT CONSULTING Learning and Performance

More information

Pharmacy Compounding: Infection Prevention

Pharmacy Compounding: Infection Prevention Pharmacy Compounding: Infection Prevention Sam Eberwein, PharmD, MS, BCPS Clinical Manager, Sterile Products Area, Perioperative Services, & Special Formulations UNC Medical Center Department of Pharmacy

More information

When it comes to managing the hazardous waste in your hospital, what you don t know you don t know can hurt you.

When it comes to managing the hazardous waste in your hospital, what you don t know you don t know can hurt you. Hazardous Hospital Wastes: What You Need to Know A White Paper for Hospital Administrators, Legal Staff, and Health, Safety & Environmental (HSE) Managers By Lori Siegelman W&M Environmental Group, LLC

More information

White Paper. Risk Management in Environmental Monitoring: Should you be spotting it sooner?

White Paper. Risk Management in Environmental Monitoring: Should you be spotting it sooner? White Paper Risk Management in Environmental Monitoring: Should you be spotting it sooner? Executive Overview Quality Risk Management is a comparatively new approach in the pharmaceutical manufacturing

More information

BIOTRAK REAL-TIME VIABLE PARTICLE COUNTER ROOT CAUSE INVESTIGATION GUIDANCE

BIOTRAK REAL-TIME VIABLE PARTICLE COUNTER ROOT CAUSE INVESTIGATION GUIDANCE BIOTRAK REAL-TIME VIABLE PARTICLE COUNTER ROOT CAUSE INVESTIGATION GUIDANCE APPLICATION NOTE CC-123 (US) Introduction This guidance provides recommendations for how the BioTrak Real-Time Viable Particle

More information

History and Update of Chapters 797 and 800

History and Update of Chapters 797 and 800 United States Pharmacopeia (USP) History and Update of Chapters 797 and 800 Lisa D. Ashworth, BS Pharm, RPh, FACA 50 th Annual C.E. Seminar Saturday, January 27, 2018, Dallas, Texas Disclaimer The views

More information

TJEMS Drug Box Program Best Practices Reviewed: Updated: November 2015

TJEMS Drug Box Program Best Practices Reviewed: Updated: November 2015 TJEMS Drug Box Program Best Practices Reviewed: Updated: November 2015 The TJEMS Drug Box Program Best Practices relate to the use of the TJEMS Drug Box. These best practices sever to provide guidance

More information

GUIDE TO INSPECTIONS OF MICROBIOLOGICAL PHARMACEUTICAL QUALITY CONTROL LABORATORIES

GUIDE TO INSPECTIONS OF MICROBIOLOGICAL PHARMACEUTICAL QUALITY CONTROL LABORATORIES GUIDE TO INSPECTIONS OF MICROBIOLOGICAL PHARMACEUTICAL QUALITY CONTROL LABORATORIES Note: This document is reference material for investigators and other FDA personnel. The document does not bind FDA,

More information

Packaging Operations Technical Subcommittee

Packaging Operations Technical Subcommittee and Sterile About the Presenter John Derek Thompson Lead Sterile Engineer, DePuy Synthes Certified Professional with the IOPP Member of the Medical Device Technical Committee Chairman of the Member of

More information

Compliance with USP 800

Compliance with USP 800 Compliance with USP 800 Patricia C. Kienle, RPh, MPA, FASHP Saad Dinno, BSPharm, RPh, FIACP, FACA International Seminar Houston, TX November 10 12, 2016 2016. All Rights Reserved. 1 Disclosure Patricia

More information

Responding to an FDA 483

Responding to an FDA 483 Responding to an FDA 483 Jim Melancon VP, Associate General Counsel BioScrip, Inc. Marc Stranz, PharmD Healthcare Consultant Disclosure The speakers declare no conflicts of interest or financial interest

More information

j) Direct and Contiguous Compounding Area refers to the specific area where a compound is prepared.

j) Direct and Contiguous Compounding Area refers to the specific area where a compound is prepared. Modified As a result of May 2011 Board meeting and discussion at Convention 61-02-01-03. Pharmaceutical compounding standards; again on September 13 th, 2011 by Katie Miller and reviewed at the September

More information

Contact Information: Laboratory Supervisor: Denise Kind Laboratory Manager: Mat Ashby

Contact Information: Laboratory Supervisor: Denise Kind Laboratory Manager: Mat Ashby Biology and Wildlife STANDARD OPERATING PROCEDURE Autoclaving Location(s): Murie 215 Chemical(s): None Specific Hazards: o steam improper use of autoclave can expose user to dangerous steam burns o extremely

More information

QUALITY ASSURANCE & AUDIT

QUALITY ASSURANCE & AUDIT QUALITY ASSURANCE & AUDIT Birinder Kaur Senior Pharmacist Pharmacy Dept National University Of Malaysia Medical Centre Kuala Lumpur birin@ppukm.ukm.edu.my LEARNING OBJECTIVES To define quality assurance

More information

USP <797> : IP + Pharmacist as partners in Medication Safety

USP <797> : IP + Pharmacist as partners in Medication Safety USP : IP + Pharmacist as partners in Medication Safety Presented by: Keith H. St. John, MS, CIC Director, Clinical Epidemiology Wolters Kluwer Health Sentri7 Clinical Solutions Disclosures "Although

More information

M I C R O B I O L O G I C A L T O O L S F O R Q U A L I T Y A S S U R A N C E I N H A T C H E R Y : Sampling Procedures

M I C R O B I O L O G I C A L T O O L S F O R Q U A L I T Y A S S U R A N C E I N H A T C H E R Y : Sampling Procedures Issue No.28 / January 2010 M I C R O B I O L O G I C A L T O O L S F O R Q U A L I T Y A S S U R A N C E I N H A T C H E R Y : Sampling Procedures by Dr Vincent TURBLIN Deputy Regional Market Manager Poultry

More information

Delegation and Technician Training. Kenneth W. Schafermeyer, PhD Senior Fellow Institute for the Advancement of Community Pharmacy Fenton, Missouri

Delegation and Technician Training. Kenneth W. Schafermeyer, PhD Senior Fellow Institute for the Advancement of Community Pharmacy Fenton, Missouri Delegation and Technician Training Kenneth W. Schafermeyer, PhD Senior Fellow Institute for the Advancement of Community Pharmacy Fenton, Missouri Learning Objectives Describe how well-trained pharmacy

More information

Entry Level Assessment Blueprint Biotechnology

Entry Level Assessment Blueprint Biotechnology Entry Level Assessment Blueprint Biotechnology Test Code: 4075 / Version: 01 Specific Competencies and Skills Tested in this Assessment: Work Habits Demonstrate professional work habits Demonstrate the

More information

HardyVal TM CSP RANDOM TEST KIT

HardyVal TM CSP RANDOM TEST KIT HardyVal TM CSP RANDOM TEST KIT Cat. no. HVR1 Random Test Kit 5 tests/kit INTENDED USE Each kit contains: Tryptic Soy Broth, Double Strength (DS), 12ml Syringe, 5.2ml Whirl-Pak Bag Results Log Sheet 5

More information

Bacterial Transformation Using Fluorescent Protein Teacher Guide

Bacterial Transformation Using Fluorescent Protein Teacher Guide Bacterial Transformation Using Fluorescent Protein Teacher Guide sciencebridge PROTOCOL 2 Bacterial Transformation using Fluorescent Protein Central question How does a change in the genotype of an organism

More information

RE: IACP Comments MA Proposed 247 CMR Sterile Compounding Regulations

RE: IACP Comments MA Proposed 247 CMR Sterile Compounding Regulations Submitted at Reg.Testimony@state.ma.us November 29, 2017 David Sencabaugh, R.Ph. Executive Director Board of Registration in Pharmacy 239 Causeway Street, 5th Floor, Ste. 500 Boston, MA 02114 RE: IACP

More information

Department of Laboratories St. Louis, MO ISSUE DATE: June 2007 REVISION DATE: May 2012 REVIEWED DATE: May 2018 PRINCIPLE:

Department of Laboratories St. Louis, MO ISSUE DATE: June 2007 REVISION DATE: May 2012 REVIEWED DATE: May 2018 PRINCIPLE: Page 1 of 7 PROCEDURE: LEAD ESA LEADCARE II / HEALTHY KIDS EXPRESS ISSUE DATE: June 2007 REVISION DATE: May 2012 REVIEWED DATE: May 2018 PRINCIPLE: The LEADCARE II System relies on electrochemistry and

More information

Preparing Your Aseptic Processing Facility for an FDA Inspection. Valerie Welter, Director Quality Bayer HealthCare March 10, 2014

Preparing Your Aseptic Processing Facility for an FDA Inspection. Valerie Welter, Director Quality Bayer HealthCare March 10, 2014 Preparing Your Aseptic Processing Facility for an FDA Inspection Valerie Welter, Director Quality Bayer HealthCare March 10, 2014 Agenda Regulatory Requirements Establishing your Approach Aseptic Controls

More information

Instructions for Use: Flexible Endoscope Sampling Kit

Instructions for Use: Flexible Endoscope Sampling Kit Instructions for Use: Flexible Endoscope Sampling Kit Brand Name of Product Generic Name of Product Product Code Number(s) Intended Use Flexible Endoscope Sampling Kit Endoscope Culture Sample Kit CK-250,

More information

Media Fill Evaluations in Cellular Therapy Product Manufacturing: Three Possible Approaches. Doug Padley Mayo Clinic

Media Fill Evaluations in Cellular Therapy Product Manufacturing: Three Possible Approaches. Doug Padley Mayo Clinic Media Fill Evaluations in Cellular Therapy Product Manufacturing: Three Possible Approaches Doug Padley Mayo Clinic Media Fill Evaluation Process Simulation Manufacturing process performed using microbiological

More information

Tissue Culture Sterilization and Contamination

Tissue Culture Sterilization and Contamination Tissue Culture lab #4 Tissue Culture Sterilization and Contamination Nowf Aldouweghri Introduction Successful cell culture depends heavily on keeping the cells free from contamination by microorganisms.

More information

Job Ready Assessment Blueprint. Biotechnology. Test Code: 4075 / Version: 01. Copyright 2014 NOCTI. All Rights Reserved.

Job Ready Assessment Blueprint. Biotechnology. Test Code: 4075 / Version: 01. Copyright 2014 NOCTI. All Rights Reserved. Job Ready Assessment Blueprint Biotechnology Test Code: 4075 / Version: 01 Copyright 2014 NOCTI. All Rights Reserved. General Assessment Information Blueprint Contents General Assessment Information Written

More information

Re: Insanitary Conditions at Compounding Facilities, Guidance for Industry (Docket ID: FDA-2016-D )

Re: Insanitary Conditions at Compounding Facilities, Guidance for Industry (Docket ID: FDA-2016-D ) Division of Dockets Management (HFA-305) Food and Drug Administration Department of Health and Human Services 5630 Fishers Lane, Room 1061 Rockville, MD 20852 [Submitted electronically to www.regulations.gov]

More information

Pacing/Teacher's Notes

Pacing/Teacher's Notes Slide 1 / 31 New Jersey Center for Teaching and Learning Progressive Science Initiative This material is made freely available at www.njctl.org and is intended for the non-commercial use of students and

More information

Biological contamination events in isolators: What lessons can be learned?

Biological contamination events in isolators: What lessons can be learned? WHITE PAPER SCIENCE DRIVEN BIO-DECONTAMINATION LS001-MKT-008 Rev 1US Biological contamination events in isolators: What lessons can be learned? James Drinkwater, Bioquell UK Process & Compliance Director.

More information

Science and Technology Feature Microbial transfer by surface contact in cleanrooms

Science and Technology Feature Microbial transfer by surface contact in cleanrooms European Journal of Parenteral & Pharmaceutical Sciences 2015; 20(4): 127-131 2015 Pharmaceutical and Healthcare Sciences Society Science and Technology Feature Microbial transfer by surface contact in

More information

Pharmaceutical compounding standards. The minimum standards and technical equipment to be considered as adequate shall include: 1.

Pharmaceutical compounding standards. The minimum standards and technical equipment to be considered as adequate shall include: 1. 61-02-01-03. Pharmaceutical compounding standards. The minimum standards and technical equipment to be considered as adequate shall include: 1. Definitions. a. "Active chemical or ingredient" refers to

More information

CERTIFICATION REPORTS, WHAT DO I NEED TO KNOW?

CERTIFICATION REPORTS, WHAT DO I NEED TO KNOW? Pharmacy Compounding Overview and Insanitary Conditions CERTIFICATION REPORTS, WHAT DO I NEED TO KNOW? 1 Introductions CDR Mary McGarry, BS, PharmD, MS, RAC, CPGP CDR Stacey Degarmo, PharmD, BCPS, CPH,

More information

Medical Device Reprocessing Assessment - General (Cleaning, Disinfection, and/or Sterilization)

Medical Device Reprocessing Assessment - General (Cleaning, Disinfection, and/or Sterilization) Medical Device Reprocessing Assessment - General (Cleaning, Disinfection, and/or Sterilization) Date: Office Name: Office Number: Responsible Physician: Assessor: M.1. General Yes No N/A If No Please Comment

More information